![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page1180.jpg)
Anti-edematous therapy
•
70-100% of all brain tumor patients receive
steroids during the course of the disease
•
Commonly rapid effect on tumor-surrounding
edema
=> reduction of mass effect
=> considerable clinical improvement is possible
=> maintenance of an acceptable quality-of-life
•
Steroid activity may decrease over time